triiodothyronine has been researched along with Auricular Fibrillation in 55 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
Excerpt | Relevance | Reference |
---|---|---|
"The purpose of this study was to evaluate serum triiodothyronine levels as a trigger of postoperative atrial fibrillation (AF) in elderly patients undergoing cardiac surgery and to study the possible association of serum triiodothyronine levels with preoperative and postoperative hemodynamics." | 9.11 | Atrial fibrillation in elderly patients after cardiac surgery: postoperative hemodynamics and low postoperative serum triiodothyronine. ( Huhtala, H; Kokkonen, L; Kööbi, T; Majahalme, S; Mustonen, J; Salmi, J; Tarkka, M; Virtanen, V, 2005) |
" Triiodothyronine-treated patients had a lower incidence of atrial fibrillation (24% versus 46%; p = 0." | 9.08 | Triiodothyronine therapy lowers the incidence of atrial fibrillation after cardiac operations. ( Gomez, M; Helm, RE; Isom, OW; Klein, IL; Klemperer, JD; Krieger, KH; Ojamaa, K, 1996) |
"We describe the effects of iopanoic acid on daily levels of free triiodothyronine (FT(3)) and free thyroxine (FT(4)) in a patient with progressive type II amiodarone-induced thyrotoxicosis (AIT) who was undergoing thyroidectomy." | 7.74 | Pharmacodynamic effect of iopanoic acid on free T(3) and T(4) levels in amiodarone-induced thyrotoxicosis. ( Falciglia, M; Matrka, L; Nikiforov, Y; Steward, D, 2008) |
"Twenty patients with thyrotoxic Basedow's disease complicated by atrial fibrillation lasting more than one month despite treatment with antithyroidal drugs were treated with radioiodine supplemented with an antithyroidal drug or inorganic iodine." | 7.68 | Reversion of thyrotoxic atrial fibrillation in hypothyroid state after radioiodine treatment. ( Fukazawa, H; Itagaki, Y; Kaise, K; Kaise, N; Saito, S; Sakurada, T; Yamamoto, M; Yoshida, K; Yoshinaga, K, 1992) |
" Subclinical hypothyroidism is diagnosed by elevated serum levels of thyroid-stimulating hormone (TSH) with thyroxine levels within the reference range, and subclinical hyperthyroidism is diagnosed by low TSH in conjunction with thyroxine and triiodothyronine levels within reference ranges." | 5.12 | Challenges in the Management of Atrial Fibrillation With Subclinical Hyperthyroidism. ( Cappola, AR; Collet, TH; Gencer, B; Rodondi, N, 2021) |
"The purpose of this study was to evaluate serum triiodothyronine levels as a trigger of postoperative atrial fibrillation (AF) in elderly patients undergoing cardiac surgery and to study the possible association of serum triiodothyronine levels with preoperative and postoperative hemodynamics." | 5.11 | Atrial fibrillation in elderly patients after cardiac surgery: postoperative hemodynamics and low postoperative serum triiodothyronine. ( Huhtala, H; Kokkonen, L; Kööbi, T; Majahalme, S; Mustonen, J; Salmi, J; Tarkka, M; Virtanen, V, 2005) |
" Triiodothyronine-treated patients had a lower incidence of atrial fibrillation (24% versus 46%; p = 0." | 5.08 | Triiodothyronine therapy lowers the incidence of atrial fibrillation after cardiac operations. ( Gomez, M; Helm, RE; Isom, OW; Klein, IL; Klemperer, JD; Krieger, KH; Ojamaa, K, 1996) |
"To analyse the efficiency of thyroid function tests (thyroid stimulating hormone, thyroxine and tri-iodothyronine) on prediction of postoperative atrial fibrillation." | 5.05 | Efficiency of Thyroid Function Test in the Prediction of Atrial Fibrillation Following Open Heart Surgery. ( Kayacioglu, I; Özdemir, K; Öztürk, I; Öztürk, S; Sensoz, Y, 2020) |
"Reports published with the following search terms were searched:, thyroid, hypothyroidism, hyperthyroidism, subclinical hyperthyroidism, subclinical hypothyroidism, levothyroxine, triiodothyronine, antithyroid drugs, radioiodine, deiodinases, clinical symptoms, heart rate, HF, systolic function, diastolic function, systemic vascular resistance, endothelial function, amiodarone and atrial fibrillation." | 4.88 | Mechanisms in endocrinology: Heart failure and thyroid dysfunction. ( Biondi, B, 2012) |
"Subclinical hyperthyroidism is defined by low or undetectable serum thyroid-stimulating hormone levels, with normal free thyroxine and total or free triiodothyronine levels." | 4.87 | Update on subclinical hyperthyroidism. ( Braunstein, GD; Donangelo, I, 2011) |
"Increased free thyroxine (FT4) and decreased thyrotropin are associated with increased risk of atrial fibrillation (AF) in observational studies, but direct involvement is unclear." | 3.91 | Assessment of the Relationship Between Genetic Determinants of Thyroid Function and Atrial Fibrillation: A Mendelian Randomization Study. ( Albert, CM; Alonso, A; Arking, DE; Benjamin, EJ; Cappola, AR; Chasman, DI; Christophersen, IE; Delgado, G; Dörr, M; Ellervik, C; Ellinor, P; Geelhoed, B; Gudnason, V; Guo, X; Heckbert, S; Homuth, G; Jukema, JW; Kleber, ME; Köttgen, A; Lin, H; Lin, HJ; Lubitz, SA; MacFarlane, P; März, W; Mooijaart, S; Mora, S; Pietzner, M; Psaty, BM; Ridker, PM; Rienstra, M; Roden, D; Roselli, C; Rotter, JI; Selvin, E; Shaffer, C; Shoemaker, MB; Sitlani, CM; Smith, AV; Sotoodehnia, N; Stott, DJ; Taylor, KD; Trompet, S; van der Harst, P; Verweij, N; Völzke, H; Weiss, S, 2019) |
"Compared to patients only taking l-thyroxine, those using liothyronine had no increased risk of cardiovascular disease [hazard ratio (HR) 1·04; 95% CI 0·70-1·54], atrial fibrillation (HR 0·91: 0·47-1·75), or fractures (HR 0·79: 0·49-1·27) after adjusting for age." | 3.83 | Liothyronine use in a 17 year observational population-based study - the tears study. ( Donnelly, LA; Leese, GP; Soto-Pedre, E, 2016) |
"A total of 1450 ambulatory community volunteer participants in the Baltimore Longitudinal Study of Aging examined at the NIA Clinical Research Unit in Baltimore, MD, have undergone longitudinal monitoring of serum thyrotropin (TSH) and thyroid hormone (free thyroxine and free triiodothryonine) levels as well as medication use every one to four years, depending on age, between 2003 and 2014." | 3.81 | Thyroid Hormone Therapy and Risk of Thyrotoxicosis in Community-Resident Older Adults: Findings from the Baltimore Longitudinal Study of Aging. ( Chia, CW; Ladenson, PW; Mammen, JS; McGready, J; Oxman, R; Simonsick, EM, 2015) |
" Heart failure represents an intriguing clinical situation in which triiodothyronine treatment might be beneficial." | 3.80 | Cardiovascular disease and thyroid function. ( Faber, J; Selmer, C, 2014) |
"We describe the effects of iopanoic acid on daily levels of free triiodothyronine (FT(3)) and free thyroxine (FT(4)) in a patient with progressive type II amiodarone-induced thyrotoxicosis (AIT) who was undergoing thyroidectomy." | 3.74 | Pharmacodynamic effect of iopanoic acid on free T(3) and T(4) levels in amiodarone-induced thyrotoxicosis. ( Falciglia, M; Matrka, L; Nikiforov, Y; Steward, D, 2008) |
"The action potential and ionic currents were investigated in single rabbit PV and atrial cardiomyocytes with (hyperthyroid) and without (control) incubation of L-triiodothyronine using the whole-cell clamp technique." | 3.71 | Effects of thyroid hormone on the arrhythmogenic activity of pulmonary vein cardiomyocytes. ( Chan, P; Chang, MS; Chen, SA; Chen, YC; Chen, YJ; Lin, CI, 2002) |
"Twenty patients with thyrotoxic Basedow's disease complicated by atrial fibrillation lasting more than one month despite treatment with antithyroidal drugs were treated with radioiodine supplemented with an antithyroidal drug or inorganic iodine." | 3.68 | Reversion of thyrotoxic atrial fibrillation in hypothyroid state after radioiodine treatment. ( Fukazawa, H; Itagaki, Y; Kaise, K; Kaise, N; Saito, S; Sakurada, T; Yamamoto, M; Yoshida, K; Yoshinaga, K, 1992) |
"Four patients are described with persistent atrial fibrillation associated with normal plasma total thyroxine (T4) and triiodothyronine (T3) but an absent plasma thyrotrophin (TSH) response to intravenous thyrotrophin releasing hormone (TRH)." | 3.66 | Atrial fibrillation and isolated suppression of the pituitary-thyroid axis: response to specific antithyroid therapy. ( Feek, CM; Forfar, JC; Miller, HC; Toft, AD, 1981) |
"Serum total thyroxine, triiodothyronine and thyrotropin response to thyrotropin-releasing hormone were measured in 75 consecutive patients presenting to a cardiology clinic with atrial fibrillation with no obvious cardiovascular cause." | 3.66 | Occult thyrotoxicosis: a correctable cause of "idiopathic" atrial fibrillation. ( Forfar, JC; Miller, HC; Toft, AD, 1979) |
"Subclinical hyperthyroidism is characterized by a clearly low serum concentration of thyrotropin (TSH) and the absence of obvious symptoms of hyperthyroidism." | 2.41 | Subclinical hyperthyroidism and atrial fibrillation. ( Sawin, CT, 2002) |
"It was shown that patients with CHD, paroxysmal atrial fibrillation and subclinical thyrotoxicosis had T3 and T4 levels 92." | 1.38 | [The influence of subclinical thyroid dysfunction on cardiac hemodynamic and electrophysiological parameters in patients with coronary heart disease and paroxysmal atrial fibrillation]. ( Khodakova, AI; Klimova, SV; Pchelinsteva, SA; Rakhmatullov, AF; Rakhmatullov, FK; Rudakova, LE, 2012) |
"Hyperthyroidism is a relative uncommon but important cause of atrial fibrillation." | 1.37 | Utility of routine thyroid-stimulating hormone determination in new-onset atrial fibrillation in the ED. ( Buccelletti, F; Carroccia, A; Franceschi, F; Gilardi, E; Marsiliani, D; Silveri, NG, 2011) |
"Hyperthyroidism has been considered to be underdiagnosed as a pathogenetic factor for atrial fibrillation, according to results of thyroliberin stimulation tests." | 1.28 | Thyrotoxic atrial fibrillation: an underdiagnosed or overdiagnosed condition? ( Darpö, B; Fagerberg, B; Lindstedt, G; Lundberg, PA; Nyström, E; Olsson, SB; Sjöström, L; Strömblad, SO, 1990) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 14 (25.45) | 18.7374 |
1990's | 7 (12.73) | 18.2507 |
2000's | 16 (29.09) | 29.6817 |
2010's | 15 (27.27) | 24.3611 |
2020's | 3 (5.45) | 2.80 |
Authors | Studies |
---|---|
Gencer, B | 1 |
Cappola, AR | 2 |
Rodondi, N | 1 |
Collet, TH | 1 |
Buber, I | 1 |
Eraydin, A | 1 |
Sevgican, CI | 1 |
Tekin, I | 1 |
Kilic, ID | 1 |
Fenkci, SM | 1 |
Öztürk, S | 1 |
Kayacioglu, I | 1 |
Sensoz, Y | 1 |
Özdemir, K | 1 |
Öztürk, I | 1 |
Wang, F | 1 |
Zhang, SJ | 1 |
Yao, X | 1 |
Tian, DM | 1 |
Zhang, KQ | 1 |
She, DM | 1 |
Guo, FF | 1 |
Zhai, QW | 1 |
Ying, H | 1 |
Xue, Y | 1 |
Wei, SB | 1 |
Wang, W | 1 |
Liu, N | 1 |
Chen, J | 1 |
Guo, XY | 1 |
Tang, RB | 1 |
Yu, RH | 1 |
Long, DY | 1 |
Sang, CH | 1 |
Jiang, CX | 1 |
Li, SN | 1 |
Wen, SN | 1 |
Wu, JH | 1 |
Bai, R | 1 |
Du, X | 1 |
Dong, JZ | 1 |
Ma, CS | 1 |
Ellervik, C | 1 |
Roselli, C | 1 |
Christophersen, IE | 1 |
Alonso, A | 1 |
Pietzner, M | 1 |
Sitlani, CM | 1 |
Trompet, S | 1 |
Arking, DE | 1 |
Geelhoed, B | 1 |
Guo, X | 1 |
Kleber, ME | 1 |
Lin, HJ | 1 |
Lin, H | 2 |
MacFarlane, P | 1 |
Selvin, E | 1 |
Shaffer, C | 1 |
Smith, AV | 1 |
Verweij, N | 1 |
Weiss, S | 1 |
Dörr, M | 1 |
Gudnason, V | 1 |
Heckbert, S | 1 |
Mooijaart, S | 1 |
März, W | 1 |
Psaty, BM | 1 |
Ridker, PM | 1 |
Roden, D | 1 |
Stott, DJ | 1 |
Völzke, H | 1 |
Benjamin, EJ | 1 |
Delgado, G | 1 |
Ellinor, P | 1 |
Homuth, G | 1 |
Köttgen, A | 1 |
Jukema, JW | 1 |
Lubitz, SA | 1 |
Mora, S | 1 |
Rienstra, M | 1 |
Rotter, JI | 1 |
Shoemaker, MB | 1 |
Sotoodehnia, N | 1 |
Taylor, KD | 1 |
van der Harst, P | 1 |
Albert, CM | 1 |
Chasman, DI | 1 |
Faber, J | 1 |
Selmer, C | 1 |
Goichot, B | 1 |
Caron, P | 1 |
Landron, F | 1 |
Bouée, S | 1 |
Mammen, JS | 1 |
McGready, J | 1 |
Oxman, R | 1 |
Chia, CW | 1 |
Ladenson, PW | 1 |
Simonsick, EM | 1 |
Leese, GP | 1 |
Soto-Pedre, E | 1 |
Donnelly, LA | 1 |
Jakowczuk, M | 1 |
Zalas, D | 1 |
Owecki, M | 1 |
Matrka, L | 1 |
Steward, D | 1 |
Falciglia, M | 1 |
Nikiforov, Y | 1 |
Gen, R | 1 |
Akbay, E | 1 |
Camsari, A | 1 |
Ozcan, T | 1 |
Cerillo, AG | 2 |
Storti, S | 2 |
Clerico, A | 2 |
Iervasi, G | 1 |
Buccelletti, F | 1 |
Carroccia, A | 1 |
Marsiliani, D | 1 |
Gilardi, E | 1 |
Silveri, NG | 1 |
Franceschi, F | 1 |
Chen, WJ | 1 |
Yeh, YH | 1 |
Lin, KH | 1 |
Chang, GJ | 1 |
Kuo, CT | 1 |
Donangelo, I | 1 |
Braunstein, GD | 1 |
Biondi, B | 1 |
Rakhmatullov, FK | 1 |
Klimova, SV | 1 |
Rudakova, LE | 1 |
Pchelinsteva, SA | 1 |
Rakhmatullov, AF | 1 |
Khodakova, AI | 1 |
Auer, J | 2 |
Berent, R | 1 |
Weber, T | 1 |
Eber, B | 2 |
Sawin, CT | 1 |
Rachmatullov, FK | 1 |
Bondarenko, LA | 1 |
Bibarsova, AM | 1 |
Kapelovich, VIu | 1 |
Osipova, VV | 1 |
Karakina, AN | 1 |
Zinov'eva, EG | 1 |
Tatarchenko, IP | 1 |
Watanabe, H | 1 |
Ma, M | 1 |
Washizuka, T | 1 |
Komura, S | 1 |
Yoshida, T | 1 |
Hosaka, Y | 1 |
Hatada, K | 1 |
Chinushi, M | 1 |
Yamamoto, T | 1 |
Watanabe, K | 1 |
Aizawa, Y | 1 |
CAVALIERI, RR | 1 |
SEARLE, GL | 1 |
Bevilacqua, S | 1 |
Mariani, M | 1 |
Kallushi, E | 1 |
Ripoli, A | 1 |
Glauber, M | 1 |
Bayer, Y | 1 |
Fasshauer, M | 1 |
Paschke, R | 1 |
Hoogendoorn, EH | 1 |
Wiersinga, WM | 1 |
Prummel, MF | 1 |
den Heijer, M | 1 |
Corstens, FH | 1 |
Hermus, AR | 1 |
Kokkonen, L | 1 |
Majahalme, S | 1 |
Kööbi, T | 1 |
Virtanen, V | 1 |
Salmi, J | 1 |
Huhtala, H | 1 |
Tarkka, M | 1 |
Mustonen, J | 1 |
Bindi, M | 1 |
Pinelli, M | 1 |
Rosada, J | 1 |
Castiglioni, M | 1 |
Gammage, MD | 1 |
Parle, JV | 1 |
Holder, RL | 1 |
Roberts, LM | 1 |
Hobbs, FD | 1 |
Wilson, S | 1 |
Sheppard, MC | 1 |
Franklyn, JA | 1 |
Mitašíková, M | 1 |
Soukup, T | 1 |
Imanaga, I | 1 |
Tribulová, N | 1 |
Kollmannsberger, A | 1 |
Kugler, J | 1 |
Schwarz, K | 1 |
Scriba, PC | 1 |
Cobler, JL | 1 |
Williams, ME | 1 |
Greenland, P | 1 |
Anastasiou-Nana, M | 1 |
Koutras, DA | 1 |
Levis, G | 1 |
Souvatzoglou, A | 1 |
Boukis, MA | 1 |
Moulopoulos, SD | 1 |
Agner, T | 1 |
Almdal, T | 1 |
Thorsteinsson, B | 1 |
Agner, E | 1 |
Forfar, JC | 2 |
Feek, CM | 1 |
Miller, HC | 2 |
Toft, AD | 2 |
Vitolo, E | 1 |
Tronci, M | 1 |
Larovere, MT | 1 |
Rumolo, R | 1 |
Morabito, A | 1 |
Klemperer, JD | 1 |
Klein, IL | 1 |
Ojamaa, K | 2 |
Helm, RE | 1 |
Gomez, M | 1 |
Isom, OW | 1 |
Krieger, KH | 1 |
Ott, RA | 1 |
Gutfinger, DE | 1 |
Miller, MP | 1 |
Alimadadian, H | 1 |
Tanner, TM | 1 |
Yeo, PP | 1 |
Loh, KC | 1 |
Gangemi, D | 1 |
Ponzetto, M | 1 |
Scarafiotti, C | 1 |
Neirotti, M | 1 |
Molaschi, M | 1 |
Fadel, BM | 1 |
Ellahham, S | 1 |
Ringel, MD | 1 |
Lindsay, J | 1 |
Wartofsky, L | 1 |
Burman, KD | 1 |
Klein, I | 1 |
Scheibner, P | 1 |
Mische, T | 1 |
Langsteger, W | 1 |
Eber, O | 1 |
Chen, YC | 1 |
Chen, SA | 1 |
Chen, YJ | 1 |
Chang, MS | 1 |
Chan, P | 1 |
Lin, CI | 1 |
Papapetrou, PD | 1 |
Jackson, IM | 1 |
Yamamoto, M | 1 |
Saito, S | 1 |
Sakurada, T | 1 |
Yoshida, K | 1 |
Kaise, K | 1 |
Kaise, N | 1 |
Fukazawa, H | 1 |
Itagaki, Y | 1 |
Yoshinaga, K | 1 |
Fagerberg, B | 2 |
Nyström, E | 2 |
Sjöström, L | 2 |
Lundberg, PA | 2 |
Darpö, B | 2 |
Lindstedt, G | 2 |
Strömblad, SO | 1 |
Olsson, SB | 1 |
Blacker, C | 1 |
Fessard, N | 1 |
Grenier, J | 1 |
Forette, B | 1 |
Schlienger, JL | 1 |
Cherfan, J | 1 |
Drawin, T | 1 |
Sacrez, A | 1 |
Tajiri, J | 1 |
Hamasaki, S | 1 |
Shimada, T | 1 |
Morita, M | 1 |
Higashi, K | 1 |
Ohishi, S | 1 |
Sato, T | 1 |
Davies, AB | 1 |
Williams, I | 1 |
John, R | 1 |
Hall, R | 1 |
Scanlon, MF | 1 |
Casey, AE | 1 |
Downey, EL | 1 |
Copeland, H | 1 |
Thomason, S | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
"Subclinical Hyperthyroidism To Treat or Not to Treat? A Dutch Multicenter Trial"[NCT00151723] | 200 participants (Anticipated) | Interventional | 2004-04-30 | Recruiting | |||
Effect of Levothyroxine on Serum Adiponectin, Insulin Resistance and Cardiovascular Risk in Patients With Hypothyroidism[NCT02467244] | 120 participants (Actual) | Observational | 2017-02-01 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
9 reviews available for triiodothyronine and Auricular Fibrillation
Article | Year |
---|---|
Challenges in the Management of Atrial Fibrillation With Subclinical Hyperthyroidism.
Topics: Age Factors; Atrial Fibrillation; Disease Management; Humans; Hyperthyroidism; Prevalence; Risk Fact | 2021 |
Efficiency of Thyroid Function Test in the Prediction of Atrial Fibrillation Following Open Heart Surgery.
Topics: Atrial Fibrillation; Cardiac Surgical Procedures; Humans; Prognosis; Thyroid Function Tests; Thyrotr | 2020 |
Update on subclinical hyperthyroidism.
Topics: Adult; Age Factors; Aged; Atrial Fibrillation; Bone Density; Cognition; Cognition Disorders; Evidenc | 2011 |
Mechanisms in endocrinology: Heart failure and thyroid dysfunction.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Coronary Disease; | 2012 |
Subclinical hyperthyroidism and atrial fibrillation.
Topics: Aged; Atrial Fibrillation; Follow-Up Studies; Humans; Hyperthyroidism; Prevalence; Risk Factors; Thy | 2002 |
[Subclinical hypothyroidism; the start of a clinical trial into the usefulness of treatment with radioactive iodine].
Topics: Atrial Fibrillation; Diagnosis, Differential; Humans; Hypothyroidism; Iodine Radioisotopes; Thyroid | 2004 |
Subclinical thyrotoxicosis.
Topics: Atrial Fibrillation; Biomarkers; Bone and Bones; Bone Density; Bone Resorption; Diagnosis, Different | 1998 |
Hyperthyroid heart disease.
Topics: Atrial Fibrillation; Heart; Heart Diseases; Heart Failure; Humans; Hyperthyroidism; Myocardial Contr | 2000 |
Thyroid hormone and the cardiovascular system.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Heart; Heart Diseases | 2001 |
3 trials available for triiodothyronine and Auricular Fibrillation
Article | Year |
---|---|
Atrial fibrillation in elderly patients after cardiac surgery: postoperative hemodynamics and low postoperative serum triiodothyronine.
Topics: Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiac Surgical Procedures; Female; Hemodynamics; | 2005 |
Amiodarone versus quinidine in the prophylaxis of atrial fibrillation.
Topics: Adult; Amiodarone; Atrial Fibrillation; Benzofurans; Clinical Trials as Topic; Coronary Disease; Fem | 1981 |
Triiodothyronine therapy lowers the incidence of atrial fibrillation after cardiac operations.
Topics: Adult; Aged; Aged, 80 and over; Atrial Fibrillation; Coronary Artery Bypass; Double-Blind Method; Fe | 1996 |
43 other studies available for triiodothyronine and Auricular Fibrillation
Article | Year |
---|---|
The effects of combination treatment with LT4 and LT3 on diastolic functions and atrial conduction time in LT4-treated women with low T3: a short term follow-up study.
Topics: Adolescent; Adult; Aged; Atrial Fibrillation; Female; Follow-Up Studies; Heart Atria; Humans; Hypoth | 2023 |
Circulating microRNA-1a is a biomarker of Graves' disease patients with atrial fibrillation.
Topics: Adult; Aged; Atrial Fibrillation; Biomarkers; Circulating MicroRNA; Female; Graves Disease; Humans; | 2017 |
U-shaped association between serum free triiodothyronine and recurrence of atrial fibrillation after catheter ablation.
Topics: Aged; Atrial Fibrillation; Biomarkers; Catheter Ablation; China; Cohort Studies; Electrocardiography | 2018 |
Assessment of the Relationship Between Genetic Determinants of Thyroid Function and Atrial Fibrillation: A Mendelian Randomization Study.
Topics: Aged; Atrial Fibrillation; Female; Genome-Wide Association Study; Humans; Hyperthyroidism; Hypothyro | 2019 |
Cardiovascular disease and thyroid function.
Topics: Adult; Aged; Aged, 80 and over; Atrial Fibrillation; Cardiovascular Diseases; Female; Heart; Heart F | 2014 |
Clinical presentation of hyperthyroidism in a large representative sample of outpatients in France: relationships with age, aetiology and hormonal parameters.
Topics: Adenoma; Adult; Age Factors; Aged; Atrial Fibrillation; Chi-Square Distribution; Female; France; Goi | 2016 |
Thyroid Hormone Therapy and Risk of Thyrotoxicosis in Community-Resident Older Adults: Findings from the Baltimore Longitudinal Study of Aging.
Topics: Aged; Aged, 80 and over; Aging; Atrial Fibrillation; Baltimore; Bone Density; Ethnicity; Female; Hea | 2015 |
Liothyronine use in a 17 year observational population-based study - the tears study.
Topics: Antipsychotic Agents; Atrial Fibrillation; Cardiovascular Diseases; Cohort Studies; Fractures, Bone; | 2016 |
Permanent atrial fibrillation in heart failure patients as another condition with increased reverse triiodothyronine concentration.
Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Case-Control Studies; Cohort Studies; Female; Heart Fa | 2016 |
Pharmacodynamic effect of iopanoic acid on free T(3) and T(4) levels in amiodarone-induced thyrotoxicosis.
Topics: Amiodarone; Atrial Fibrillation; Contrast Media; Humans; Iopanoic Acid; Male; Middle Aged; Thyroidec | 2008 |
P-wave dispersion in endogenous and exogenous subclinical hyperthyroidism.
Topics: Adenocarcinoma, Follicular; Adenoma; Atrial Fibrillation; Carcinoma, Papillary; Electrocardiography; | 2010 |
Thyroid function and cardiac surgery: what should we measure, and when?
Topics: Atrial Fibrillation; Coronary Artery Bypass; Humans; Hypothyroidism; Thyroid Function Tests; Thyrotr | 2010 |
Utility of routine thyroid-stimulating hormone determination in new-onset atrial fibrillation in the ED.
Topics: Aged; Atrial Fibrillation; Chi-Square Distribution; Confidence Intervals; Cross-Sectional Studies; E | 2011 |
Molecular characterization of thyroid hormone-inhibited atrial L-type calcium channel expression: implication for atrial fibrillation in hyperthyroidism.
Topics: Action Potentials; Animals; Atrial Fibrillation; Calcium; Calcium Channels, L-Type; Cell Line; Colla | 2011 |
[The influence of subclinical thyroid dysfunction on cardiac hemodynamic and electrophysiological parameters in patients with coronary heart disease and paroxysmal atrial fibrillation].
Topics: Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Disease; Electrophysiological Phenomena | 2012 |
Thyroid hormone and arrhythmogenic activity.
Topics: Animals; Atrial Fibrillation; Biomarkers; Humans; Hyperthyroidism; Risk Factors; Thyrotropin; Triiod | 2002 |
[Hemodynamics, electrophysiological parameters of the heart and differential therapy of attacks of atrial fibrillation in patients with subclinical thyroid dysfunction].
Topics: Adult; Anti-Arrhythmia Agents; Antithyroid Agents; Atrial Fibrillation; Data Interpretation, Statist | 2003 |
Thyroid hormone regulates mRNA expression and currents of ion channels in rat atrium.
Topics: Action Potentials; Animals; Atrial Fibrillation; Atrial Function; Calcium Channels, L-Type; Cells, C | 2003 |
THE DIALYSIS OF I-131 TRIIODOTHYRONINE FROM PLASMA: AN IN VITRO TEST OF THYROID FUNCTION.
Topics: Atrial Fibrillation; Dialysis; Erythrocytes; Heart Failure; Hyperthyroidism; Hypothyroidism; In Vitr | 1965 |
Free triiodothyronine: a novel predictor of postoperative atrial fibrillation.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Atrial Fibrillation; Biomarkers; Coronary Arte | 2003 |
The novel missense mutation methionine 442 threonine in the thyroid hormone receptor beta causes thyroid hormone resistance: a case report.
Topics: Atrial Fibrillation; Goiter, Nodular; Humans; Male; Methionine; Middle Aged; Mutation, Missense; Ped | 2004 |
[Atrial fibrillation and thyroid gland].
Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Female; Humans; Hyperthyroidism; Hypothyroidism; Male; | 2005 |
Association between serum free thyroxine concentration and atrial fibrillation.
Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Cohort Studies; Electrocardiography; Female; Humans; M | 2007 |
Diabetes and thyroid hormones affect connexin-43 and PKC-epsilon expression in rat heart atria.
Topics: Animals; Atrial Fibrillation; Blood Glucose; Connexin 43; Diabetes Mellitus, Experimental; Heart Atr | 2009 |
[The thyreotoxic encephalopathy].
Topics: Adult; Atrial Fibrillation; Brain; Brain Diseases; Cardiovascular Diseases; Electroencephalography; | 1967 |
Thyrotoxicosis in institutionalized elderly patients with atrial fibrillation.
Topics: Aged; Atrial Fibrillation; Female; Hospitals, Chronic Disease; Humans; Hyperthyroidism; Male; New Yo | 1984 |
The correlation of serum amiodarone levels with abnormalities in the metabolism of thyroxine.
Topics: Aged; Amiodarone; Atrial Fibrillation; Benzofurans; Female; Humans; Male; Middle Aged; Thyrotropin; | 1984 |
A reevaluation of atrial fibrillation in thyrotoxicosis.
Topics: Adenoma; Adolescent; Adult; Aged; Atrial Fibrillation; Female; Humans; Hyperthyroidism; Male; Middle | 1984 |
Atrial fibrillation and isolated suppression of the pituitary-thyroid axis: response to specific antithyroid therapy.
Topics: Atrial Fibrillation; Electric Countershock; Humans; Hyperthyroidism; Thyrotropin; Thyrotropin-Releas | 1981 |
Rapid recovery after coronary artery bypass grafting: is the elderly patient eligible?
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiopulmonary Bypass; Case-Control Studies; Con | 1997 |
Atrial fibrillation and thyroid function in elderly hospitalized subjects.
Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Female; Hospitalization; Humans; Hyperthyroidism; Male | 1999 |
Subclinical hyperthyroidism as a risk factor for atrial fibrillation.
Topics: Atrial Fibrillation; Comorbidity; Humans; Hyperthyroidism; Middle Aged; Risk Factors; Thyrotropin; T | 2001 |
Effects of thyroid hormone on the arrhythmogenic activity of pulmonary vein cardiomyocytes.
Topics: Action Potentials; Animals; Atrial Fibrillation; Electrophysiologic Techniques, Cardiac; Heart; Hype | 2002 |
Thyrotoxicosis due to "silent" thyroiditis.
Topics: Adult; Atrial Fibrillation; Circadian Rhythm; Female; Goiter; Humans; Hyperthyroidism; Iodine Radioi | 1975 |
Occult thyrotoxicosis: a correctable cause of "idiopathic" atrial fibrillation.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Carbimazole; Female; Heart Failure; Humans; Hyperthyroidi | 1979 |
Reversion of thyrotoxic atrial fibrillation in hypothyroid state after radioiodine treatment.
Topics: Adult; Atrial Fibrillation; Autoantibodies; Female; Graves Disease; Humans; Hypothyroidism; Iodine; | 1992 |
[Importance of investigating the function of the thyroid gland in patients with chronic atrial fibrillation].
Topics: Atrial Fibrillation; Chronic Disease; Graves Disease; Humans; Hyperthyroidism; Middle Aged; Thyroid | 1991 |
Thyrotoxic atrial fibrillation: an underdiagnosed or overdiagnosed condition?
Topics: Aged; Atrial Fibrillation; Female; Humans; Hyperthyroidism; Immunoenzyme Techniques; Male; Middle Ag | 1990 |
[Thyroid function in normal aged subjects or with auricular fibrillation].
Topics: Aged; Aged, 80 and over; Aging; Atrial Fibrillation; Female; Humans; Male; Middle Aged; Thyroid Glan | 1989 |
[Systematic ultrasensitive determination of thyroid-stimulating hormone in 50 cases of atrial fibrillation].
Topics: Adult; Aged; Aged, 80 and over; Atrial Fibrillation; Female; Humans; Hyperthyroidism; Male; Middle A | 1988 |
Masked thyroid dysfunction among elderly patients with atrial fibrillation.
Topics: Aged; Antibodies; Atrial Fibrillation; Female; Humans; Hyperthyroidism; Injections, Intravenous; Mal | 1986 |
Diagnostic value of thyrotrophin releasing hormone tests in elderly patients with atrial fibrillation.
Topics: Aged; Atrial Fibrillation; Female; Humans; Hyperthyroidism; Male; Prospective Studies; Thyrotropin; | 1985 |
Paroxysmal tachycardia, atrial fibrillation, congestive heart failure, protein-bound iodine and tri-iodothyronine.
Topics: Atrial Fibrillation; Blood Proteins; Humans; Iodine; Protein Binding; Tachycardia, Paroxysmal; Triio | 1973 |